GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GLMD
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Galmed Pharmaceuticals Ltd. stock price after Friday trading.
(Updated on Apr 19, 2024)

Buy candidate since Apr 19, 2024 PDF

The Galmed Pharmaceuticals Ltd. stock price fell by -1.56% on the last day (Friday, 19th Apr 2024) from $0.379 to $0.373. During the last trading day the stock fluctuated 2.30% from a day low at $0.370 to a day high of $0.379. The price has been going up and down for this period, and there has been a 9.94% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -9 thousand shares and in total, 18 thousand shares were bought and sold for approximately $6.71 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.84% during the next 3 months and, with a 90% probability hold a price between $0.283 and $0.397 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GLMD Signals & Forecast

The Galmed Pharmaceuticals Ltd. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.384. On a fall, the stock will find some support from the long-term average at approximately $0.355. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 5.22%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Galmed Pharmaceuticals Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.339 and $0.311. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Galmed Pharmaceuticals Ltd. finds support just below today's level at $0.339. If this is broken, then the next support from accumulated volume will be at $0.311 and $0.305.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0085 between high and low, or 2.30%. For the last week the stock has had daily average volatility of 8.83%.

Our recommended stop-loss: $0.358 (-3.96%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (GLMD) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Galmed Pharmaceuticals Ltd. to open at $0.374, and during the day (based on 14 day Average True Range), to move between $0.338 and $0.407, which gives a possible trading interval of +/-$0.0345 (+/-9.26%) up or down from last closing price. If Galmed Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 18.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.380 (1.93%) than the support at $0.339 (9.04%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Galmed Pharmaceuticals Ltd. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.797 Buy Candidate Upgraded

Predicted Opening Price for Galmed Pharmaceuticals Ltd. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.374 ( 0.259%) $0.373

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GLMD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.382 2.54 %
R2 0.379 1.67 %
R1 0.377 1.13 %
Current price: 0.373
Support S1 0.371 -0.612 %
S2 0.369 -1.15 %
S3 0.365 -2.02 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.396 6.20 %
R2 0.389 4.27 %
R1 0.380 1.93 %
Current price 0.373
Support S1 0.339 -9.04%
S2 0.311 -16.66%
S3 0.305 -18.16%

FAQ

What is the symbol for Galmed Pharmaceuticals Ltd. Stock and on which exchange is it traded?
The symbol for Galmed Pharmaceuticals Ltd. is GLMD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Galmed Pharmaceuticals Ltd. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Galmed Pharmaceuticals Ltd. Stock?
Galmed Pharmaceuticals Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Galmed Pharmaceuticals Ltd. Stock.

What's the current price of Galmed Pharmaceuticals Ltd. Stock?
As of the end of day on the 2024-04-19, the price of an Galmed Pharmaceuticals Ltd. (GLMD) share was $0.373.

What is the 52-week high and low for Galmed Pharmaceuticals Ltd. Stock?
The 52-week high for Galmed Pharmaceuticals Ltd. Stock is $5.63 and the 52-week low is $0.260.

What is the market capitalization of Galmed Pharmaceuticals Ltd. Stock?
As of the 2024-04-19, the market capitalization of Galmed Pharmaceuticals Ltd. is 1.442M.

When is the next earnings date for Galmed Pharmaceuticals Ltd.?
The upcoming earnings date for Galmed Pharmaceuticals Ltd. is May 30, 2024.
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT